Related Experiment Video

Updated: Aug 11, 2026

Measurement of Basal and Forskolin-stimulated Lipolysis in Inguinal Adipose Fat Pads
07:59

Measurement of Basal and Forskolin-stimulated Lipolysis in Inguinal Adipose Fat Pads

Published on: July 21, 2017

Pharmacotherapy to reduce visceral fat

George L Blackburn1, Belinda A Waltman

  • 1Division of Nutrition, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA. gblackbu@bidmc.harvard.edu

Clinical Cornerstone
|February 14, 2006
PubMed

Insights

Reducing visceral fat through weight loss lowers cardiovascular disease (CVD) risk. A smaller waist circumference improves metabolic health markers, indicating better overall health and reduced disease risk.

Area of Science:

  • Cardiovascular health
  • Metabolic disease
  • Obesity research

Background:

  • Cardiovascular disease (CVD) is a primary cause of mortality in the US.
  • Visceral adipose tissue accumulation, distinct from subcutaneous fat, elevates CVD and metabolic disease risks.
  • Waist circumference is emerging as a superior health risk indicator for overweight and obesity compared to body mass index.

Purpose of the Study:

  • To highlight the distinct role of visceral adipose tissue in CVD and insulin resistance.
  • To emphasize the clinical significance of waist circumference as a health risk marker.
  • To underscore the benefits of weight loss, specifically waist circumference reduction, on metabolic parameters.

Main Methods:

  • Analysis of the relationship between visceral adipose tissue and CVD risk factors.
  • Comparison of waist circumference and body mass index as predictors of health risks.
  • Evaluation of the impact of weight loss on insulin sensitivity, lipid profiles, and adipocytokines.

Main Results:

  • Visceral fat accumulation is a key contributor to CVD and metabolic dysfunction.
  • Reduced waist circumference correlates with improved insulin sensitivity.
  • Weight loss, indicated by decreased waist circumference, positively affects lipid profiles and serum adipocytokines.

Conclusions:

  • Targeting visceral adipose tissue reduction is crucial for mitigating CVD and metabolic disease.
  • Waist circumference serves as a clinically valuable metric for assessing health risks associated with obesity.
  • Weight loss interventions focused on reducing waist circumference can significantly improve metabolic health and lower chronic disease risk.

More Related Videos

An Acupoint Catgut-embedding Therapy for Treating Obesity04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

Multidisciplinary Approach to Obesity Management: A Case Report05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...